Neil Romberg1, Carole Le Coz2, Salomé Glauzy3, Jean-Nicolas Schickel3, Melissa Trofa2, Brian E Nolan4, Michele Paessler5, Mina L Xu6, Michele P Lambert7, Saquib A Lakhani8, Mustafa K Khokha9, Soma Jyonouchi10, Jennifer Heimall10, Patricia Takach11, Paul J Maglione12, Jason Catanzaro13, F Ida Hsu14, Kathleen E Sullivan10, Charlotte Cunningham-Rundles12, Eric Meffre15. 1. Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. Electronic address: rombergn@email.chop.edu. 2. Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa. 3. Department of Immunobiology, Yale University School of Medicine, New Haven, Conn. 4. Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pa. 5. Division of Hematopathology, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 6. Department of Pathology, Yale University School of Medicine, New Haven, Conn. 7. Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 8. Department of Pediatrics, Yale University School of Medicine, New Haven, Conn; Pediatric Genomics Discovery Program, Yale University School of Medicine, New Haven, Conn. 9. Department of Pediatrics, Yale University School of Medicine, New Haven, Conn; Department of Genetics, Yale University School of Medicine, New Haven, Conn; Pediatric Genomics Discovery Program, Yale University School of Medicine, New Haven, Conn. 10. Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 11. Department of Medicine, Division of Allergy and Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 12. Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. 13. Department of Pediatrics, Yale University School of Medicine, New Haven, Conn. 14. Department of Medicine, Yale University School of Medicine, New Haven, Conn. 15. Department of Immunobiology, Yale University School of Medicine, New Haven, Conn; Department of Medicine, Yale University School of Medicine, New Haven, Conn. Electronic address: eric.meffre@yale.edu.
Abstract
BACKGROUND: The lack of pathogen-protective, isotype-switched antibodies in patients with common variable immunodeficiency (CVID) suggests germinal center (GC) hypoplasia, yet a subset of patients with CVID is paradoxically affected by autoantibody-mediated autoimmune cytopenias (AICs) and lymphadenopathy. OBJECTIVE: We sought to compare the physical characteristics and immunologic output of GC responses in patients with CVID with AIC (CVID+AIC) and without AIC (CVID-AIC). METHODS: We analyzed GC size and shape in excisional lymph node biopsy specimens from 14 patients with CVID+AIC and 4 patients with CVID-AIC. Using paired peripheral blood samples, we determined how AICs specifically affected B-and T-cell compartments and antibody responses in patients with CVID. RESULTS: We found that patients with CVID+AIC displayed irregularly shaped hyperplastic GCs, whereas GCs were scarce and small in patients with CVID-AIC. GC hyperplasia was also evidenced by an increase in numbers of circulating follicular helper T cells, which correlated with decreased regulatory T-cell frequencies and function. In addition, patients with CVID+AIC had serum endotoxemia associated with a dearth of isotype-switched memory B cells that displayed significantly lower somatic hypermutation frequencies than their counterparts with CVID-AIC. Moreover, IgG+ B cells from patients with CVID+AIC expressed VH4-34-encoded antibodies with unmutated Ala-Val-Tyr and Asn-His-Ser motifs, which recognize both erythrocyte I/i self-antigens and commensal bacteria. CONCLUSIONS: Patients with CVID+AIC do not contain mucosal microbiota and exhibit hyperplastic yet inefficient GC responses that favor the production of untolerized IgG+ B-cell clones that recognize both commensal bacteria and hematopoietic I/i self-antigens.
BACKGROUND: The lack of pathogen-protective, isotype-switched antibodies in patients with common variable immunodeficiency (CVID) suggests germinal center (GC) hypoplasia, yet a subset of patients with CVID is paradoxically affected by autoantibody-mediated autoimmune cytopenias (AICs) and lymphadenopathy. OBJECTIVE: We sought to compare the physical characteristics and immunologic output of GC responses in patients with CVID with AIC (CVID+AIC) and without AIC (CVID-AIC). METHODS: We analyzed GC size and shape in excisional lymph node biopsy specimens from 14 patients with CVID+AIC and 4 patients with CVID-AIC. Using paired peripheral blood samples, we determined how AICs specifically affected B-and T-cell compartments and antibody responses in patients with CVID. RESULTS: We found that patients with CVID+AIC displayed irregularly shaped hyperplastic GCs, whereas GCs were scarce and small in patients with CVID-AIC. GC hyperplasia was also evidenced by an increase in numbers of circulating follicular helper T cells, which correlated with decreased regulatory T-cell frequencies and function. In addition, patients with CVID+AIC had serum endotoxemia associated with a dearth of isotype-switched memory B cells that displayed significantly lower somatic hypermutation frequencies than their counterparts with CVID-AIC. Moreover, IgG+ B cells from patients with CVID+AIC expressed VH4-34-encoded antibodies with unmutated Ala-Val-Tyr and Asn-His-Ser motifs, which recognize both erythrocyte I/i self-antigens and commensal bacteria. CONCLUSIONS:Patients with CVID+AIC do not contain mucosal microbiota and exhibit hyperplastic yet inefficient GC responses that favor the production of untolerized IgG+ B-cell clones that recognize both commensal bacteria and hematopoietic I/i self-antigens.
Authors: Susanne Unger; Maximilian Seidl; Annette Schmitt-Graeff; Joachim Böhm; Klaudia Schrenk; Claudia Wehr; Sigune Goldacker; Ruth Dräger; Barbara C Gärtner; Paul Fisch; Martin Werner; Klaus Warnatz Journal: J Clin Immunol Date: 2014-05-02 Impact factor: 8.317
Authors: Tineke Cantaert; Jean-Nicolas Schickel; Jason M Bannock; Yen-Shing Ng; Christopher Massad; Fabien R Delmotte; Natsuko Yamakawa; Salome Glauzy; Nicolas Chamberlain; Tuure Kinnunen; Laurence Menard; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Julie Bruneau; Waleed Al-Herz; Sara Sebnem Kilic; Hans D Ochs; Charlotte Cunningham-Rundles; Mirjam van der Burg; Taco W Kuijpers; Sven Kracker; Hideo Kaneko; Yujin Sekinaka; Shigeaki Nonoyama; Anne Durandy; Eric Meffre Journal: J Clin Invest Date: 2016-10-04 Impact factor: 14.808
Authors: Zahra Sabouri; Peter Schofield; Keisuke Horikawa; Emily Spierings; David Kipling; Katrina L Randall; David Langley; Brendan Roome; Rodrigo Vazquez-Lombardi; Romain Rouet; Jana Hermes; Tyani D Chan; Robert Brink; Deborah K Dunn-Walters; Daniel Christ; Christopher C Goodnow Journal: Proc Natl Acad Sci U S A Date: 2014-05-12 Impact factor: 11.205
Authors: F E Johansen; M Pekna; I N Norderhaug; B Haneberg; M A Hietala; P Krajci; C Betsholtz; P Brandtzaeg Journal: J Exp Med Date: 1999-10-04 Impact factor: 14.307
Authors: Yang Zhang; Michael Meyer-Hermann; Laura A George; Marc Thilo Figge; Mahmood Khan; Margaret Goodall; Stephen P Young; Adam Reynolds; Francesco Falciani; Ari Waisman; Clare A Notley; Michael R Ehrenstein; Marie Kosco-Vilbois; Kai-Michael Toellner Journal: J Exp Med Date: 2013-02-18 Impact factor: 14.307
Authors: Carole Le Coz; Bertram Bengsch; Caroline Khanna; Melissa Trofa; Takuya Ohtani; Brian E Nolan; Sarah E Henrickson; Michele P Lambert; Taylor Olmsted Kim; Jenny M Despotovic; Scott Feldman; Olajumoke O Fadugba; Patricia Takach; Melanie Ruffner; Soma Jyonouchi; Jennifer Heimall; Kathleen E Sullivan; E John Wherry; Neil Romberg Journal: J Allergy Clin Immunol Date: 2019-08-22 Impact factor: 10.793
Authors: Marcel Kuhny; Lisa R Forbes; Elif Çakan; Andrea Vega-Loza; Valentyna Kostiuk; Ravi K Dinesh; Salomé Glauzy; Asbjorg Stray-Pedersen; Ashley E Pezzi; I Celine Hanson; Alexander Vargas-Hernandez; Mina LuQuing Xu; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Ivan K Chinn; David G Schatz; Jordan S Orange; Eric Meffre Journal: J Clin Invest Date: 2020-08-03 Impact factor: 14.808
Authors: Holly M Jacobs; Tanvi Arkatkar; Samuel W Du; Nicole E Scharping; Jonathan Woods; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; David J Rawlings; Shaun W Jackson Journal: Eur J Immunol Date: 2021-06-27 Impact factor: 6.688